Schinus terebinthifolius Raddi extract and linoleic acid from Passiflora edulis synergistically decrease melanin synthesis in B16 cells and reconstituted epidermis.
Several treatments for skin whitening are available today, but few of them are completely adequate, especially owing to the carcinogenic potential attributed to classical drugs like hydroquinone, arbutin and kojic acid. To provide an alternative and safer technology for whitening, we developed two botanical compounds originated from Brazilian biodiversity, an extract of Schinus terebinthifolius Raddi and a linoleic acid fraction isolated from Passiflora edulis oil. The whitening effect of these compounds was assessed using biochemical assays and in vitro models including cellular assays and equivalent skin. The results showed that S. terebinthifolius Raddi extract is able to reduce the tyrosinase activity in vitro, and the combination of this extract with linoleic acid is able to decrease the level of melanin produced by B16 cells cultured with melanocyte-stimulating hormone. Furthermore, melanin was also reduced in human reconstituted epidermis (containing melanocytes) treated with the compounds. The combination of the compounds may provide a synergistic positive whitening effect rather than their isolated use. Finally, we demonstrated that the performance of these mixed compounds is comparable to classical molecules used for skin whitening, as kojic acid. This new natural mixture could be considered an alternative therapeutic agent for treating hyperpigmentation and an effective component in whitening cosmetics.
Natura Innovation and Product Technology Ltda, Cajamar, São Paulo, Brazil.
A T S
AT
Jorge
K F
KF
Arroteia
I A
IA
Santos
E
E
Andres
S P H
SP
Medina
C R
CR
Ferrari
C B
CB
Lourenço
R M T T
RM
Biaggio
P L
PL
Moreira
D027926:Anacardiaceae / Q000737:chemistry*; D000818:Animals; D041702:BALB 3T3 Cells; D001938:Brazil; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects; D004817:Epidermis / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D020128:Inhibitory Concentration 50; D019787:Linoleic Acid / Q000494:pharmacology*; D008297:Male; D008543:Melanins / Q000037:antagonists & inhibitors* / Q000096:biosynthesis* / Q000378:metabolism; D008544:Melanocytes / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D008546:Melanoma, Experimental / Q000378:metabolism; D051379:Mice; D014442:Monophenol Monooxygenase / Q000037:antagonists & inhibitors / Q000378:metabolism; D029598:Passiflora / Q000737:chemistry*; D010936:Plant Extracts / Q000494:pharmacology*; D062327:Skin Lightening Preparations / Q000494:pharmacology*
D008543:Melanins; D010936:Plant Extracts; D062327:Skin Lightening Preparations; D019787:Linoleic Acid; D014442:Monophenol Monooxygenase